Seven quality guidelines for breast, colorectal cancer care

The American Society of Clinical Oncology and the National Comprehensive Cancer Network on Tuesday released seven quality guidelines for breast and colorectal cancer care, CQ Today reports.

The guidelines are based on clinical impact, feasibility, potential for improvement, reliability, scientific acceptability and usefulness.

They include post-operative chemotherapy recommendations for people ages 80 and younger; hormonal therapy recommendations for people with tumors one centimeter or larger; and breast radiation therapy recommendations for women ages 70 or younger (CQ Today, 8/17).

According to the guidelines, the recommendations -- three breast cancer-related, two rectal cancer-related, one colon cancer-related and one colorectal cancer-related -- continually will be tested by the organizations and will be updated to reflect the findings of such tests (ASCO/NCCN, "ASCO/NCCN Quality Measures: Breast and Colorectal Cancers," 8/15).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI model could help clinicians to understand prostate tumor's aggressiveness